Showing results (111-120 of 160) with videos related to
Sort By:
Pageof 16
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular DystrophyFoluso Agboola, Grace A Lin, Noemi Fluetsch, et al.Journal of Comparative Effectiveness Research|November 15, 2023
Institute for Clinical and Economic Review - Peterson Health Technology Institute value assessment framework for digital health technologiesSteven D Pearson, Prabhjot Singh, Francesca Beaudoin, et al.Journal of Managed Care & Specialty Pharmacy|January 28, 2021
The effectiveness and value of novel treatments for cystic fibrosisJeffrey A Tice, Karen M Kuntz, Kael Wherry, et al.Journal of the American Academy of Dermatology|February 14, 2018
Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysisAnne M Loos, Shanshan Liu, Celia Segel, et al.Neurology|January 13, 2022
Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer DiseaseMelanie D Whittington, Jonathan D Campbell, David Rind, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2020
The effectiveness and value of novel acute treatments for migraineFoluso Agboola, Steven J Atlas, Daniel R Touchette, et al.Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetesGregory F Guzauskas, David M Rind, Katherine Fazioli, et al.Journal of Managed Care & Specialty Pharmacy|December 28, 2018
The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin AmyloidosisKristin Mickle, Karen E Lasser, Jeffrey S Hoch, et al.Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Gene therapies for sickle cell disease: Effectiveness and valueDmitriy Nikitin, Francesca L Beaudoin, Praveen Thokala, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Evaluating the Importance of Heterogeneity of Treatment Effect: Variation in Patient Utilities Can Influence Choice of the "Optimal" Oral Anticoagulant for Atrial FibrillationChristopher G Cameron, Patricia G Synnott, Steven D Pearson, et al.Pageof 16